Aernoud Fiolet

205 The efficacy and safety of low-dose colchicine in patients with coronary disease 17 Supplementary Appendix Supplementary Figure S4B: Sensitivity analysis of meta-analysis of colchicine trials excluding the non- placebo controlled trial LoDoCo for the individual secondary end points Myocardial infarction Stroke Coronary revascularisation Supplementary Figure S4B: Sensitivity analysis of meta-analysis of colchicine trials excluding the non-plac bo controlled trial LoDoCo for the individual secondary end points Pooled relative risks and 95% confidence intervals for the individual components of the composite end points in patients treated with colchicine as compared to placebo or no colchicine excluding the non-placebo controlled trial LoDoCo. Abbreviations: CI, confidence interval. GIV, generic inverse variance.